(Q39550477)
Statements
Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro (English)
Rakesh K Singh
Lee Dorf
Angelica DeMartino
Sharon Illenye
Karen Koto
Erika A Currier
Takamaru Ashikaga
Kyu Kwang Kim
Giselle L Saulnier Sholler